Hardick Justin, Maldeis Nancy, Theodore Mellisa, Wood Billie Jo, Yang Samuel, Lin Shin, Quinn Thomas, Gaydos Charlotte
Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.
J Mol Diagn. 2004 May;6(2):132-6. doi: 10.1016/S1525-1578(10)60501-6.
Chlamydia pneumoniae (CPN) causes pneumonia in humans, and has emerged as an important respiratory pathogen. There are also established links between CPN infection and coronary artery disease. Traditional culture methods for CPN detection can be time consuming and difficult. There are a variety of molecular-based amplification methods for CPN detection. These methods are more sensitive than culture, but have the disadvantage of being inconsistent and non-comparable across studies. In this paper, we describe the adaptation of the existing primer set CPN 90/CPN91 for use in a real-time PCR assay using the Roche Lightcycler and a Taqman probe. This assay had an analytical sensitivity of between 4 and 0.4 infection-forming units (IFUs)/PCR reaction. A total of 355 samples were tested for validation of the assay. Tested samples included two standardized panels of blinded samples from culture (N = 70), archived specimens consisting of a CPN dilution series, CPN-spiked porcine aortal tissue and endarterectomy specimens (N = 87). The third group consisted of prospectively collected PBMCs from clinical samples (N = 198). Results were compared to nested PCR, which targets the ompA gene of CPN; TETR PCR, which targets the 16S rRNA gene of CPN; or the known result for the sample. Overall, the assay had a sensitivity of 88.5% (69 of 78) and a specificity of 99.3% (275 of 277). This method should prove useful for accurate, high throughput detection of CPN.
肺炎衣原体(CPN)可导致人类肺炎,已成为一种重要的呼吸道病原体。CPN感染与冠状动脉疾病之间也存在已确定的联系。传统的CPN检测培养方法可能耗时且困难。有多种基于分子的扩增方法用于CPN检测。这些方法比培养更敏感,但存在研究结果不一致且不可比的缺点。在本文中,我们描述了现有的引物对CPN 90/CPN91在使用罗氏Lightcycler和Taqman探针的实时PCR检测中的应用。该检测的分析灵敏度为4至0.4感染形成单位(IFU)/PCR反应。总共测试了355个样本以验证该检测。测试样本包括来自培养的两个标准化盲样组(N = 70)、由CPN稀释系列、CPN加标的猪主动脉组织和动脉内膜切除术标本组成的存档标本(N = 87)。第三组由前瞻性收集的临床样本中的外周血单核细胞(PBMC)组成(N = 198)。将结果与靶向CPN的ompA基因的巢式PCR、靶向CPN的16S rRNA基因的TETR PCR或样本的已知结果进行比较。总体而言,该检测的灵敏度为88.5%(78个样本中的69个),特异性为99.3%(277个样本中的275个)。该方法应被证明对CPN的准确、高通量检测有用。